Alzheimer’s Group Resources

[News of the Week] Pharmacology: The Puzzling Rise and Fall of a Dark-Horse Alzheimer’s Drug

The announcement last week that a closely watched phase III clinical trial for Alzheimer's disease had failed to show a significant effect deals yet another demoralizing blow to patients, families, and caregivers.Author: Greg Miller (Source: Science: Current Issue)

Alzheimer’s Society comment on new research which indicates that individual episodic memory traces can be decoded in hippocampus

Dr Susanne Sorensen comment, (Source: Alzheimers Society)

New Alzheimer’s test offers better opportunities

Early detection is key to more effective therapy for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities linked to these diseases. The test, called CST -- for computerized self test -- was designed to be both effective and relatively simple for medical professionals to administer and for patients to take........ (Source: Medicineworld.org: New Article Alert)

New Alzheimer’s test offers better opportunities

Early detection is key to more effective therapy for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities linked to these diseases. The test, called CST -- for computerized self test -- was designed to be both effective and relatively simple for medical professionals to administer and for patients to take........ (Source: Medicineworld.org: New Article Alert)

Alzheimer’s Test That Can Be Administered In Family Practitioners’ Offices Offers Better Opportunities For Early Detection

Early detection is key to more effective treatment for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities associated with these diseases...

Mimetics of hormetic agents: stress-resistance triggers.

Authors: Sonneborn JS Mimetics of hormetic agents offer a novel approach to adjust dose to minimize the risk of toxic response, and maximize the benefit of induction of at least partial physiological conditioning. Nature selected and preserved those organisms and triggers that promote tolerance to stress. The induced tolerance can serve to resist that challenge and can repair previous age, disease, and trauma damage as well to provide a more youthful response to other stresses. The associated physiological conditioning may include youthful restoration of DNA repair, resistance to oxidizing pollutants, protein structure and function repair, improved immunity, tissue remodeling, adjustments in central and peripheral nervous systems, and altered metabolism. By elucidating common pathways ...

Mimetics of hormetic agents: stress-resistance triggers.

Authors: Sonneborn JS Mimetics of hormetic agents offer a novel approach to adjust dose to minimize the risk of toxic response, and maximize the benefit of induction of at least partial physiological conditioning. Nature selected and preserved those organisms and triggers that promote tolerance to stress. The induced tolerance can serve to resist that challenge and can repair previous age, disease, and trauma damage as well to provide a more youthful response to other stresses. The associated physiological conditioning may include youthful restoration of DNA repair, resistance to oxidizing pollutants, protein structure and function repair, improved immunity, tissue remodeling, adjustments in central and peripheral nervous systems, and altered metabolism. By elucidating common pathways ...

Alzheimer’s Test That Can Be Administered In Family Practitioners’ Offices Offers Better Opportunities For Early Detection

Early detection is key to more effective treatment for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities associated with these diseases. The test, called CST -- for computerized self test -- was designed to be both effective and relatively simple for medical professionals to administer and for patients to take. Rex Cannon, an adjunct research assistant professor of psychology at UT Knoxville, and Dr... (Source: Health News from Medical News Today)

Allon’s Phase 1 Trial Broadens Davunetide’s Intranasal Safety And Dose Range

Allon Therapeutics Inc. (TSX:NPC) announced today that a Phase 1 clinical trial of its lead neuroprotective drug, davunetide , which began patient enrolment January 28, 2010, has been completed. The results demonstrated that the intranasal dose range can be broadened and provided additional information on the pharmacokinetic profile of davunetide...

Allon’s Phase 1 Trial Broadens Davunetide’s Intranasal Safety And Dose Range

Allon Therapeutics Inc. (TSX:NPC) announced today that a Phase 1 clinical trial of its lead neuroprotective drug, davunetide , which began patient enrolment January 28, 2010, has been completed. The results demonstrated that the intranasal dose range can be broadened and provided additional information on the pharmacokinetic profile of davunetide... (Source: Alzheimer's / Dementia News From Medical News Today)